Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a post-translational modification that modulates ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease.

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by ...

According to MarketsandMarkets™, the Proteins & Protein Crystals Market is projected to grow from about USD 609.51 billion in ...

Cancer immunotherapy has reshaped cancer treatment by training the body's immune system to recognize and attack tumors. Drugs ...